US 12,012,421 B2
Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
Katja Grosse-Sender, Basel (CH); Urs Schwitter, Basel (CH); Frank Stowasser, Basel (CH); Xuemei Wang, Shanghai (CN); and Jing Xiong, Shanghai (CN)
Assigned to Hoffmann-La Roche Inc., Little Falls, NJ (US)
Filed by Hoffmann-La Roche Inc., Little Falls, NJ (US)
Filed on Dec. 23, 2021, as Appl. No. 17/645,876.
Application 17/645,876 is a continuation of application No. 16/476,172, granted, now 11,230,559, previously published as PCT/EP2018/050160, filed on Jan. 4, 2018.
Prior Publication US 2022/0119415 A1, Apr. 21, 2022
Int. Cl. C07D 513/04 (2006.01); A61P 31/20 (2006.01)
CPC C07D 513/04 (2013.01) [A61P 31/20 (2018.01); C07B 2200/13 (2013.01)] 13 Claims
 
1. A solid form of compound (I),

OG Complex Work Unit Chemistry
or a salt, or a solvate thereof, wherein the form is Form A, Form B, or Form G, or a combination thereof.